A clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, we focus our clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology.
Lead Underwriter
Cowen and Company, LLC, J.P. Morgan Securities LLC, Piper Sandler & Co
